Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy.

Elevated choline (Cho) level has been documented on proton magnetic resonance spectroscopy ((1)H MRS) in head and neck squamous cell carcinoma and therefore percentage changes in Cho levels after chemoradiotherapy may serve as a marker of residual cancer in a post-treatment mass (PTM). Forty-six pat...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 20; no. 1; pp. 165 - 173
Autores principales: King AD, Yeung DK, Yu KH, Mo FK, Hu CW, Bhatia KS, Tse GM, Vlantis AC, Wong JK, Ahuja AT, King, Ann D, Yeung, David K W, Yu, Kwok-Hung, Mo, Frankie K F, Hu, Chen-Wen, Bhatia, Kunwar S, Tse, Gary M K, Vlantis, Alexander C, Wong, Jeffrey K T, Ahuja, Anil T
Formato: research Journal Article
Publicado: Springer Nature Jan2010
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105285605&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105285605
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Jan2010
      vid: 20
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        105285605
        47410914
        NLM19652977
        2010528180
        10.1007/s00330-009-1531-2
        NLM19652977
        105285605
      ppf: 165
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy.
      aug:
        au:
          King AD
          Yeung DK
          Yu KH
          Mo FK
          Hu CW
          Bhatia KS
          Tse GM
          Vlantis AC
          Wong JK
          Ahuja AT
          King, Ann D
          Yeung, David K W
          Yu, Kwok-Hung
          Mo, Frankie K F
          Hu, Chen-Wen
          Bhatia, Kunwar S
          Tse, Gary M K
          Vlantis, Alexander C
          Wong, Jeffrey K T
          Ahuja, Anil T
        affil: Department of Diagnostic Radiology and Organ Imaging, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong SAR, China
      sug:
        subj:
          Choline Analysis
          Head and Neck Neoplasms Diagnosis
          Head and Neck Neoplasms Therapy
          Magnetic Resonance Spectroscopy Methods
          Protons Diagnostic Use
          Tumor Markers, Biological Analysis
          Chemotherapy, Adjuvant
          Diagnosis, Computer Assisted Methods
          Female
          Head and Neck Neoplasms Metabolism
          Human
          Male
          Prognosis
          Radiotherapy, Adjuvant
          Reproducibility of Results
          Sensitivity and Specificity
          Treatment Outcomes
          Female
          Male
      ab: Elevated choline (Cho) level has been documented on proton magnetic resonance spectroscopy ((1)H MRS) in head and neck squamous cell carcinoma and therefore percentage changes in Cho levels after chemoradiotherapy may serve as a marker of residual cancer in a post-treatment mass (PTM). Forty-six patients underwent (1)H MRS before treatment and the 30 patients with a PTM underwent repeat (1)H MRS at 6 weeks post-treatment. The percentage change in Cho/creatine and Cho/water ratios were correlated with residual cancer. The mean pretreatment Cho/creatine and Cho/water ratios were 2.24 and 1.20 x 10(-3), respectively. Cho persisted in four out of nine PTMs with residual cancer. Cho was absent in five out of nine PTMs with residual cancer and 21/21 PTMs without cancer. The number of PTMs with persistent Cho was too small to allow analysis of percentage change in ratios but the presence of Cho in a PTM showed significant correlation with residual cancer (p = 0.0046), producing a sensitivity, specificity, positive predictive value and negative predictive value of 44%, 100%, 100% and 81%, respectively. Therefore, the presence of Cho in a PTM may serve as a marker of residual cancer. Furthermore since so few PTMs contain Cho, a percentage change in Cho ratios may not be a useful method for monitoring treatment response.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N